Subscribe Now For Just $36.75 Instead Of $49 Enjoy 1 Month Of Unlimited Access At A 25% Discount And Save $12.25. Don’t Miss Out – Use Your Discount Code Today !
1W4MO5IH
Click Here
Contract Awards
Total
7
contracts found.
7
contracts are listing.
Advanced Filters
Tender ID | Title | Country | Awarded Date | |
---|---|---|---|---|
Infliximab (czechia-prague: Immunosuppressive Agen... *****
Organization:
*****
Language:
English
|
Czech Republic
|
03.06.2019 | ||
Lanreotide (czechia-prague: Pituitary, Hypothalami... *****
Organization:
*****
Language:
English
|
Czech Republic
|
03.06.2019 | ||
Fulvestrant (czechia-prague: Endocrine Therapy Med... *****
Organization:
*****
Language:
English
|
Czech Republic
|
22.04.2019 | ||
Aflibercept (czechia-prague: Ophthalmologicals) Cz... *****
Organization:
*****
Language:
English
|
Czech Republic
|
17.04.2019 | ||
Infliximab (czech Republic-prague: Immunosuppressi... *****
Organization:
*****
Language:
English
|
Czech Republic
|
26.02.2019 | ||
Ustekinumab (czech Republic-prague: Immunosuppress... *****
Organization:
*****
Language:
English
|
Czech Republic
|
26.02.2019 | ||
Aminolevulic Acid (czech Republic-prague: Antineop... *****
Organization:
*****
Language:
English
|
Czech Republic
|
07.02.2019 |
Infliximab (czechia-prague: Immunosuppressive Agents) Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
03.06.2019
Lanreotide (czechia-prague: Pituitary, Hypothalamic Hormones And Analogues) Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
03.06.2019
Fulvestrant (czechia-prague: Endocrine Therapy Medicinal Products) Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
22.04.2019
Aflibercept (czechia-prague: Ophthalmologicals) Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
17.04.2019
Infliximab (czech Republic-prague: Immunosuppressive Agents) Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
26.02.2019
Ustekinumab (czech Republic-prague: Immunosuppressive Agents) Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
26.02.2019
Aminolevulic Acid (czech Republic-prague: Antineoplastic Agents) Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
07.02.2019